Airway Therapeutics Announces FDA Acceptance of IND for AT-100... - 12 April 2021 18:00

CINCINNATI, Apr. 12, 2021 /PRNewswire-AsiaNet/ -- -- Initiating Phase 1b clinical trial with initial results expected 3Q2021 -- Potential for novel therapeutic AT-100 to inhibit viral replication, promote viral elimination and reduction of lung injury, inflammation, and secondary infections in...

  GenScript, Parkway Laboratories and Diagnostics Development (D... - 12 April 2021 15:35

SINGAPORE, April 12, 2021 /PRNewswire-AsiaNet/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass(TM) SARS-CoV-2 neutralizing antibody test in Singapore through Park...

  Korea's Outstanding SMEs as Frontline Fighters against COVID-19 - 12 April 2021 11:00

SEOUL, South Korea, April 12, 2021 /PRNewswire-AsiaNet/ -- BSR Korea is encouraging and supporting decent and respectful domestic SMEs of prophylaxis industry to enter the global procurement-as-a-service market, as the government-entrusted organizing agency of the COVID-19 quarantine project, Marketing Su...

  Copan, putting Covid-19 challenges behind and setting up for t... - 10 April 2021 03:13

BRESCIA, Italy, April 10, 2021 /PRNewswire-AsiaNet/ -- With an email to the main distributors, Copan group's CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges. Photo - https://mma.prnewswire.com/me...

  RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passe... - 09 April 2021 21:00

TEL AVIV, Israel and RALEIGH, N.C., April 9, 2021 /PRNewswire-AsiaNet/ -- - Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients ...

  Control Bionics (ASX:CBL) Partners with Numotion as Northeaste... - 09 April 2021 06:56

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 9, 2021 /PRNewswire-AsiaNet/ -- -- Strategic Partnership Offers Customers More Access to Control Bionics' Industry-Leading Trilogy Product Line Control Bionics ( https://c212.net/c/link/?t=0&l=en&o=3123587-1&h=2005398914&u=https%3A%2F%2Fwww.controlbionics.com%2F&a=Control+Bio...

  Shanghai Genechem Co., Ltd. (Genechem) Announces appointment o... - 09 April 2021 00:35

SHANGHAI, April 8, 2021 /PRNewswire-AsiaNet/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, I...

  Shanghai Genechem Co., Ltd. (Genechem) Announces Global Collab... - 07 April 2021 01:05

SHANGHAI, April 6, 2021 /PRNewswire-Asianet/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global b...

  Gan & Lee receives EMA orphan drug designation for Phase I dru... - 06 April 2021 22:05

BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire-AsiaNet/-- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products granted orphan d...

  Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover - 06 April 2021 06:58

GAITHERSBURG, Md., April 6, 2021 /PRNewswire-AsiaNet/ -- -- Crossover allows participants to continue in trials and remain blinded -- Ensures that all trial participants receive active vaccine -- South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned Novavax, Inc. (N...